The anticonvulsant hypothesis of the mechanisms of action of ECT: Current status

Journal of ECT

Volumn 15, Issue 1, 1999, Pages 5-26

  Sackeim, Harold A ^a,b  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Anticonvulsant effects; Electroconvulsive therapy; Seizures

Indexed keywords

ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN BLOOD FLOW; COGNITIVE DEFECT; CONVULSION; DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMAN; SEIZURE THRESHOLD; SLOW BRAIN WAVE;

ANTICONVULSANTS; BRAIN; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; HUMANS; REGIONAL BLOOD FLOW; SEIZURES;

EID: 0032983033     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (119)

1. Abrams R. Electroconvulsive Therapy. New York: Oxford University Press, 1997.
2. Abrams R, Taylor MA, Volavka J. ECT-induced EEG asymmetry and therapeutic response in melancholia: relation to treatment electrode placement. Am J Psychiatry 1987;144:327-9.
3. Abrams R, Volavka J, Schrift M. Brief pulse ECT in melancholia: EEG and clinical effects. J Nerv Ment Dis 1992;180:55-7.
4. Ackermann RF, Engel J Jr, Baxter L. Positron emission tomography and autoradiographic studies of glucose utilization following electroconvulsive seizures in humans and rats. Ann NY Acad Sci 1986;462:263-9.
5. American Psychiatric Association. Electroconvulsive Therapy, Task Force Report 14. Washington, DC: American Psychiatric Association, 1978.
6. Andrews PR, Johnson GAR. GABA agonists and antagonists. Biochem Pharmacol 1979;28:2697-702.
7. Tc99mhexamethylpropyleneamineoxime and single photon emission computed tomography. Acta Psychiatr Scand 1989;80:421-6.
8. Ball CJ, Gloor P, Schaul N. The cortical electromicrophysiology of pathological delta waves in the electroencephalogram of the cat. Electroencephalogr Clin Neurophysiol 1977;43:346-61.
9. Beresford HR, Posner JB, Plum F. Changes in brain lactate during induced cerebral seizures. Arch Neurol 1969;20:243-8.
10. Bolwig TG, Hertz MM, Paulson OB, Spotoft H, Rafaelsen OJ. The permeability of the blood-brain barrier during electrically induced seizures in man. Eur J Clin Invest 1977;7:87-93.
11. Bonne O, Krausz Y, Shapira B, Bocher M, Karger H, Gorfine M, Chisin R, Lerer B. Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. J Nucl Med 1996;37:1075-80.
12. Bowery WG, Simmonds MA, Hill RG. Bicyclic phosphorus esters that are potent convulsants and GABA antagonists. Nature 1976;261:601.
13. Brodersen P, Paulson OB, Bolwig TG, Rogon ZE, Rafaelsen OJ, Lassen NA. Cerebral hyperemia in electrically induced epileptic seizures. Arch Neurol 1973;28:334-8.
14. Calvet J, Calvet MC, Scherer J. Etude stratigraphique corticale de l'activité EEG spontanée. Electroencephalogr Clin Neurophysiol 1964;17:109-125.
15. Coffey CE, Figiel GS, Weiner RD, Saunders WB. Caffeine augmentation of ECT. Am J Psychiatry 1990;147:579-85.
16. Coffey CE, Lucke J, Weiner RD, Krystal AD, Aque M. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biol Psychiatry 1995a;37:713-20.
17. Coffey CE, Lucke J, Weiner RD, Krystal AD, Aque M. Seizure threshold in electroconvulsive therapy (ECT) II: the anticonvulsant effect of ECT. Biol Psychiatry 1995b;37:777-88.
18. Devanand DP, Sackeim HA. Seizure elicitation blocked by pretreatment with lidocaine. Convulsive Ther 1988;4:225-9.
19. di Michele V, Giordano L, de Cataldo S, Sabatini MD, Petruzzi C, Casacchia M, Rossi A. Electroencephalographic seizure duration in electroconvulsive therapy: a clinical study. Convulsive Ther 1992;8:258-61:
20. Duncan R. Epilepsy, cerebral blood flow, and cerebral metabolic rate. Cerebrovasc Brain Metab Rev 1992;4:105-21.
21. Duncan R, Patterson J, Roberts R, Hadley DM, Bone I. Ictal/postictal SPECT in the pre-surgical localisation of complex partial seizures. J Neurol Neurosurg Psychiatry 1993;56:141-8.
22. Engel JJ. Seizures and epilepsy. Philadelphia: FA Davis, 1989.
23. Engel JJ, Kuhl DE, Phelps ME. Patterns of human local cerebral glucose metabolism during epileptic seizures. Science 1982a;218:64-6.
24. Engel JJ, Kuhl DE, Phelps ME, Mazziota JC. Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann Neurol 1982b;12:529-37.
25. Essig CF. The effect of an anticonvulsant on the seizure threshold elevation caused by repeated electroconvulsions. Arch Int Pharmacodyn Ther 1968;173:189-94.
26. Essig CF. Frequency of repeated electroconvulsions and the acquisition rate of a tolerance-like response. Exp Neurol 1969;25:571-4.
27. Essig CF, Flanary HG. The importance of the convulsion in occurrence and rate of development of electroconvulsive threshold elevation. Exp Neurol 1966;14:448-52.
28. Essig CF, Groce ME, Williamson EL. Electroconvulsive threshold elevation: From daily stimulation of adrenalectomized animals. Science 1963;140:828-9.
29. Fink M. Convulsive therapy: theory and practice. New York: Raven Press, 1979.
30. Fink M, Kahn RL. Relation of electroencephalographic delta activity to behavioral response in electroshock: quantitative serial studies. Arch Neurol Psychiatry 1957;78:516-25.
31. Fochtmann LJ. Animal studies of electroconvulsive therapy: foundations for future research. Psychopharmacol Bull 1994;30:321-444.
32. Folkerts H. The ictal electroencephalogram as a marker for the efficacy of electroconvulsive therapy. Eur Arch Psychiatry Clin Neurosci 1996;246:155-64.
33. 2 receptors, adenylate cyclase, and the adenosine uptake site. J Neurochem 1989;52:641-6.
34. Green A, Nutt D. Psychopharmacology of repeated seizures: possible relevance to the mechanisms of action of electroconvulsive therapy. In: L Iversen, S Iversen, S Snyder, eds. Handbook of Psychopharmacology, Vol. 19. New York: Plenum Press, 375-419, 1987.
35. Green A, Nutt D, Cowen P Increased seizure threshold following convulsion. In: Sandler M, ed. Psychopharmacology of anticonvulsants. Oxford: Oxford University Press, 1982:16-26.
36. Green MA. Relation between threshold and duration of seizures and electrographic change during convulsive therapy. J Nerv Ment Dis 1960;131:117-20.
37. Guze BH, Baxter LRJ, Schwartz JM, Szuba MP, Liston EH. Electroconvulsive therapy and brain glucose metabolism. Convulsive Ther 1991;7:15-19.
38. Holaday JW, Tortella FC, Meyerhoff JL, Belenky GL, Hitzemann RJ. Electroconvulsive shock activates endogenous opioid systems: behavioral and biochemical correlates. Ann NY Acad Sci 1986;467:249-55.
39. Ingvar M. Cerebral blood flow and metabolic rate during seizures: relationship to epileptic brain damage. Ann N Y Acad Sci 1986;462:194-206.
40. Isaac L, Schoenbeck R, Bacher J, Skolnick P, Paul SM. Electroconvulsive shock increases endogenous monoamine oxidase inhibitor activity in brain and cerebrospinal fluid. Neurosci Lett 1986;66:257-62.
41. Isaac L, Swanger J. Alteration of electroconvulsive threshold by cerebrospinal fluid from cats tolerant to electroconvulsive shock. Life Sci 1983;33:2301-4.
42. Jarvis MR, Zorumski CF, Goewert AJ, Rasmussen KG. Maintenance electroconvulsive therapy and seizure duration. Convulsive Ther 1993;9:8-13.
43. Johnson LC, Ulett GA, Sines JO, Stern JA. Cortical activity and cognitive functioning. Electroencephalogr Clin Neurophysiol 1960;12:861-74.
44. Kales H, Raz J, Tandon R, Maixner D, DeQuardo J, Miller A, Becks L. Relationship of seizure duration to anti-depressant efficacy in electroconvulsive therapy. Psychol Med 1997;27:1373-80.
45. Kalinowsky LB, Kennedy F. Observation in electroschock therapy applied to problems in epilepsy. J Nerv Ment Dis 1943;98:56-67.
46. Kety SS, Woodford RB, Harmel MH, Freyhan FA, Appel KE, Schmidt CF. Cerebral blood flow and metabolism in schizophrenia. Am J Psychiatry 1948;104:765-70.
47. Kragh J, Tonder N, Finsen BR, Zimmer J, Bolwig TG. Repeated electroconvulsive shocks cause transient changes in rat hippocampal somatostatin and neuropeptide Y immunoreactivity and mRNA in situ hybridization signals. Exp Brain Res 1994;98:305-13.
48. Krueger RB, Fama JM, Devanand DP, Prudic J, Sackeim HA. Does ECT permanently alter seizure threshold? Biol Psychiatry 1993;33:272-6.
49. Krystal AD, Coffey CE, Weiner RD, Rapp PE, Albano A, Greenside HS, DeMasi M, Cellucci C, EEG correlates of the response to ECT. Biol Psychiatry 1997;41:56S.
50. Krystal AD, Weiner RD. ECT seizure therapeutic adequacy. Convulsive Ther 1994;10:153-64.
51. Krystal AD, Weiner RD, Coffey CE. The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT. J Neuropsychiatry Clin Neurosci 1995;7:295-303.
52. Krystal AD, Weiner RD, Coffey CE, McCall WV. Effect of ECT treatment number on the ictal EEG. Psychiatry Res 1996;62:179-89.
53. Krystal AD, Weiner RD, McCall WV, Shelp FE, Arias R, Smith P. The effect of ECT stimulus dose and electrode placement on the ictal electroencephalogram: an intraindividual crossover study. Biol Psychiatry 1993;34:759-67.
54. Leentjens AF, van den Broek WW, Kusuma A, Bruijn JA. Facilitation of ECT by intravenous administration of theophylline. Convulsive Ther 1996;12:232-7.
55. Lloyd KG, Morselli PL, Bartholini G. GABA and affective disorders. Med Biol 1987;65:159-65.
56. Lloyd KG, Thuret F, Pile A. Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. J Pharmacol Exp Ther 1985;235:191-9.
57. Maletzky BM. Seizure duration and clinical effect in electroconvulsive therapy. Comp Psychiatry 1978;19:541-50.
58. Margerison JH, Corsellis JA. Epilepsy and the temporal lobes: a clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966;89:499-530.
59. McCall WV, Colenda CC, Farah BA. Ictal EEG regularity declines during a course of RUL ECT. Convulsive Ther 1996a;12:213-6.
60. McCall WV, Reid S, Rosenquist P, Foreman A, Kiesow-Webb N. A reappraisal of the role of caffeine in ECT. Am J Psychiatry 1993;150:1543-5.
61. McCall WV, Robinette GD, Hardesty D. Relationship of seizure morphology to the convulsive threshold. Convulsive Ther 1996b;12:147-51.
62. Mikkelsen JD, Woldbye D, Kragh J, Larsen PJ, Bolwig TG. Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus. Brain Res Mol Brain Res 1994;23:317-22.
63. Mukherjee S. Mechanisms of the antimanic effect of electroconvulsive therapy. Convulsive Ther 1989;5:227-43.
64. Nobler MS, Luber BK, Katzman, GP, Prudic J, Devanand DP, Sackeim HA. Quantitative EEG during ECT: relations to clinical characteristics and treatment modality. Presented at the 36th Annual Meeting of the American College of Neuropsychopharmacology, December 8, 1997.
65. Nobler MS, Sackeim HA. Mechanisms of action of electroconvulsive therapy: Functional brain imaging studies. Psychiatric Annals 1998;28:23-9.
66. Nobler MS, Sackeim HA, Prohovnik I, Moeller JR, Mukherjee S, Schnur DB, Prudic J, Devanand DP. Regional cerebral blood flow in mood disorders. III. Treatment and clinical response. Arch Gen Psychiatry 1994;51:884-97.
67. Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J. EEG manifestations during ECT: effects of electrode placement and stimulus intensity. Biol Psychiatry 1993;34:321-30.
68. Ottosson J-O. Experimental studies of the mode of action of electroconvulsive therapy. Acta Psychiatr Scand Suppl 1960;145:1-141.
69. Ottosson J-O. Electroconvulsive therapy of endogenous depression: an analysis of the influence of various factors on the efficacy of the therapy. J Ment Sci 1962; 108:694-703.
70. Petsche H, Pockberger H, Rappelsberger P. On the search for the sources of the electroencephalogram. Neuroscience 1984;11:1-27.
71. Plum F, Posner JB, Troy B. Cerebral metabolic and circulatory responses to induced convulsions in animals. Arch Neurol 1968;18:1-13.
72. Post RM. ECT: the anticonvulsant connection [see comments. Neuropsychopharmacology 1990;3:89-92.
73. Post RM, Putnam F, Uhde TW, Weiss SR. Electroconvulsive therapy as an anticonvulsant: implications for its mechanism of action in affective illness. Ann NY Acad Sci 1986;462:376-88.
74. Prohovnik I, Sackeim HA, Decina P, Malitz S. Acute reductions of regional cerebral blood flow following electroconvulsive therapy: Interactions with modality and time. Ann N Y Acad Sci 1986;462:249-62.
75. Riddle WJ, Scott AI, Bennie J, Carroll S, Fink G. Current intensity and oxytocin release after electroconvulsive therapy. Biol Psychiatry 1993;33:839-41.
76. Robin A, Binnie CD, Copas JB. Electrophysiological and hormonal responses to three types of electroconvulsive therapy. Br J Psychiatry 1985;147:707-12.
77. Roemer RA, Dubin WR, Jaffe R, Lipschutz L, Sharon D. An efficacy study of single-versus double-seizure induction with ECT in major depression. J Clin Psychiatry 1990;51:473-8.
78. Rosenberg R, Vorstrup S, Anderson A, Bolwig TG. Effect of ECT on cerebral blood flow in melancholia assessed with SPECT. Convulsive Ther 1988;4:62-73.
79. Roth M. Changes in the EEG under barbiturate anesthesia produced by electroconvulsive treatment and their significance for the theory of ECT action. EEG Clin Neurophysiol 1951;3:261-80.
80. Roth M, Kay DW, Shaw J, Green J. Prognosis and pentothal induced electroencephalographic changes in electroconvulsive treatment: an approach to the problem of regulation of convulsive therapy. EEG Clin Neurophysiol 1957;9:225-37
81. Sackeim HA. Central issues regarding the mechanisms of action of electroconvulsive therapy: directions for future research. Psychopharmacol Bull 1994;30:281-308.
82. Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S. Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry 1987a;144:1449-55.
83. Sackeim HA, Decina P, Portnoy S, Neeley P, Malitz S. Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry 1987c;22:249-68.
84. Sackeim HA, Decina P, Prohovnik I, Malitz S. Seizure threshold in electroconvulsive therapy: effects of sex, age, electrode placement, and number of treatments. Arch Gen Psychiatry 1987b;44:355-60.
85. Sackeim HA, Decina P, Prohovnik I, Malitz S, Resor SR. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry 1983;18:1301-10.
86. Sackeim HA, Decina P, Prohovnik I, Portnoy S, Kanzler M, Malitz S. Dosage, seizure threshold, and the antidepressant efficacy of electroconvulsive therapy. Ann NY Acad Sci 1986;462:398-410.
87. Sackeim HA, Devanand DP, Nobler MS. Electroconvulsive therapy. In: Bloom F, Kupfer D, eds. Psychopharmacology: the fourth generation of progress. New York: Raven, 1995:1123-42.
88. Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am 1991;14:803-43.
89. Sackeim HA, Long J, Luber B, Moeller JR, Prohovnik I, Devanand DP, Nobler MS. Physical properties and quantification of the ECT stimulus: I. Basic principles. Convulsive Ther 1994;10:93-123.
90. Sackeim HA, Luber B, Katzman GP, Moeller JR, Prudic J, Devanand DP, Nobler MS. The effects of electroconvulsive therapy on quantitative electroencephalograms: relationship to clinical outcome. Arch Gen Psychiatry 1996;53:814-24.
91. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 1993;328:839-46.
92. Schwindt PC, Spain WJ, Crill WE. Long-lasting reduction of excitability by a sodium-dependent potassium current in cat neocortical neurons. J Neurophysiol 1989;61:233-44.
93. 99mTc-exametazime into brain in major depression shown with single photon emission tomography. J Affect Disord 1994;30:27-34.
94. Sestoft D, Meden P, Hemmingsen R, Hancke B, Madsen PL, Friberg L. Disparity in regional cerebral blood flow during electrically induced seizure. Acta Psychiatr Scand 1993;88:140-3.
95. Shapira B, Lerer B, Gilboa D, Drexler H, Kugelmass S, Calev A. Facilitation of ECT by caffeine pretreatment. Am J Psychiatry 1987;144:1199-202.
96. Shapira B, Lidsky D, Gorfine M, Lerer B. Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold. J Clin Psychiatry 1996;57:32-8.
97. Silfverskiöld P, Gustafson L, Risberg J, Rosën I. Acute and late effects of electroconvulsive therapy: clinical outcome, regional cerebral blood flow, and electroencephalogram. Ann NY Acad Sci 1986;462:236-48.
98. Silfverskiöld P, Risberg J. Regional cerebral blood flow in depression and maria. Arch Gen Psychiatry 1989;46:253-9.
99. Silfverskiöld P, Rosën I, Risberg J. Effects of electroconvulsive therapy on EEG and cerebral blood flow in depression. Eur Arch Psychiatry Neurol Sci 1987;236:202-8.
100. Simmonds MA. Leptazol as a gamma aminobutyric acid antagonist. Br J Pharmacol 1980;70:75P.
101. Steriade M. Cellular substrates of brain rhythms. In: Niedermeyer E, Lopes da Silva FH, eds. Electroencephalography: basic principles, clinical applications, and related fields.. 3rd ed. Baltimore: Williams & Wilkins, 1994:27-62.
102. Steriade M, Buzsáki G. Parallel activation of thalamic and cortical neurons by brainstem and basal forebrain cholinergic systems. In: Steriade M, Biesold D, eds. Brain cholinergic systems. New York: Oxford University Press, 1990:3-62.
103. Strömgren LS, Juul-Jensen P. EEG in unilateral and bilateral electroconvulsive therapy. Acta Psychiatr Scand 1975;51:340-60.
104. Suppes T, Webb A, Carmody T, Gordon E, Gutierrez-Esteinou R, Hudson JI, Pope HG Jr. Is postictal electrical silence a predictor of response to electroconvulsive therapy? J Affect Disord 1996;41:55-8.
105. Swartz CM, Lewis RK. Theophylline reversal of electroconvulsive therapy (ECT) seizure inhibition. Psychosomatics 1991;32:47-51.
106. Taylor RM, Pacella BL. The significance of abnormal electroencephalograms prior to electroconvulsive therapy. J Nerv Ment Dis 1948;107:220-227.
107. Tomasson K, Winokur G, Pfohl B. Failed and short seizures associated with prior electroconvulsive therapy. Eur Arch Psychiatry Clin Neurosci 1992;241:307-13.
108. Tortella FC, Long JB. Endogenous anticonvulsant substance in rat cerebrospinal fluid after a generalized seizure. Science 1985;228:1106-8.
109. Tortella FC, Long JB. Characterization of opioid peptide-like anticonvulsant activity in rat cerebrospinal fluid. Brain Res 1988;456:139-46.
110. Tortella FC, Long JB, Hong J, Holaday JW. Modulation of endogenous opioid systems by electroconvulsive shock. Convulsive Ther 1989;5:261-73.
111. Valmier J, Touchon J, Daures P, Zanca M, Baldy-Moulinier M. Correlations between cerebral blood flow variations and clinical parameters in temporal lobe epilepsy: an interictal study. J Neurol Neurosurg Psychiatry 1987;50:1306-11.
112. Volavka J, Feldstein S, Abrams R, Dornbush R, Fink M. EEG and clinical change after bilateral and unilateral electroconvulsive therapy. Electroencephalogr Clin Neurophysiol 1972;32:631-9.
113. Volkow ND, Bellar S, Mullani N, Jould L, Dewey S. Effects of electroconvulsive therapy on brain glucose metabolism: a preliminary study. Convulsive Ther 1988;4:199-205.
114. Weiner RD. The psychiatric use of electrically induced seizures. Am J Psychiatry 1979;136:1507-17.
115. Weiner RD. The persistence of electroconvulsive therapy-induced changes in the electroencephalogram. J Nerv Ment Dis 1980;168:224-8.
116. Weiner RD, Rogers HJ, Davidson JR, Kahn EM. Effects of electroconvulsive therapy upon brain electrical activity. Ann N Y Acad Sci 1986;462:270-81.
117. Wilson WP, Schieve JF, Scheinberg P. Effect of series of electric shock treatments on cerebral blood flow and metabolism. Arch Neurol Psychiatry 1952;68:651-4.
118. Yatham LN, Barry S, Dinan TG, Webb M. Which patients will respond to ECT? Br J Psychiatry 1989;154:879-80.
119. Zis AP, Yatham LN, Lam RW, Clark CM, Srisurapanont M, McGarvey K. Effect of stimulus intensity on prolactin and cortisol release induced by unilateral electroconvulsive therapy. Neuropsychopharmacology 1996;15: 263-70.